{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:21:57Z","timestamp":1767864117491,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.contraception.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T00:31:25Z","timestamp":1303259485000},"page":"508-511","source":"Crossref","is-referenced-by-count":12,"title":["A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24\/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21\/7 combined oral contraceptive in the treatment of hirsutism"],"prefix":"10.1016","volume":"84","author":[{"given":"Gokalp","family":"Oner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iptisam Ipek","family":"Muderris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.03.002_bb0005","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003081-199009000-00028","article-title":"Hyperandrogenic disorders","volume":"33","author":"Barbieri","year":"1990","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00001703-199510000-00004","article-title":"Advances in the diagnosis and treatment of the hirsute patient","volume":"7","author":"Knochenhauer","year":"1995","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09513590801948309","article-title":"Treatment of hirsutism with combined pill containing drospirenone","volume":"24","author":"Gregoriou","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.rigp.2004.05.001","article-title":"The modern management of hirsutism","volume":"4","author":"Ol\u00e1h","year":"2004","journal-title":"Rev Gynaecol Practise"},{"key":"10.1016\/j.contraception.2011.03.002_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0015-0282(16)53212-9","article-title":"Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women","volume":"53","author":"Murphy","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.03.002_bb0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0029-7844(02)02725-4","article-title":"The evaluation and management of hirsutism","volume":"101","author":"Azziz","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.002_bb0040","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2011.03.002_bb0045","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2011.03.002_bb0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.fertnstert.2005.07.1311","article-title":"Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism","volume":"85","author":"Batukan","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.03.002_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.002_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.002_bb0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.002_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.03.002_bb0075","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/humrep\/17.10.2495","article-title":"What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome","volume":"17","author":"Homburg","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.03.002_bb0080","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/13625180008500407","article-title":"A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers","volume":"5","author":"Blode","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.03.002_bb0090","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2003-031158","article-title":"Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study","volume":"89","author":"Guido","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.03.002_bb0095","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00024677-200302010-00005","article-title":"Ethinylestradiol\/drospirenone: a review of its use as an oral contraceptive","volume":"2","author":"Keam","year":"2003","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09637480601137066","article-title":"Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism","volume":"23","author":"Batukan","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0110","first-page":"261","article-title":"Extracontraceptive benefits of EE\/DRSP (Yaz) in 24+4 day regimen","volume":"62","author":"Bruni Bresciani","year":"2010","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.contraception.2011.03.002_bb0115","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0030-1248139","article-title":"Recent innovations in oral contraception","volume":"28","author":"Cremer","year":"2010","journal-title":"Semin Reprod Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T04:52:10Z","timestamp":1543812730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0010782411001028"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.03.002","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}